| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 7,905 | $25.30 | $199,996.50 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 8,787 | $53.00 | $465,711.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 7,905 | $0.00 | $0.00 | View Details Filing |
| Mar 5, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 10,000 | $53.71 | $537,100.00 | View Details Filing |
| Feb 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 4,475 | $0.00 | $0.00 | View Details Filing |
| Feb 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | D | 4,475 | $0.00 | $0.00 | View Details Filing |
| Feb 23, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 15,000 | $12.98 | $194,700.00 | View Details Filing |
| Feb 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 4,977 | $0.00 | $0.00 | View Details Filing |
| Feb 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 2,989 | $0.00 | $0.00 | View Details Filing |